Johnson & Johnson announced that TECNIS Eyhance intraocular lens (IOL), the industry’s first enhanced monofocal IOL[8] has now been implanted in more than 10 million eyes globally[1], reinforcing its position as the established market leader in the enhanced monofocal category.[2-3]
As cataract surgeons continue to seek technologies that meet growing patient expectations for intermediate vision without compromising distance clarity, TECNIS Eyhance IOL stands apart as the most clinically validated and fastest growing solution in the category it created.[2,4]
“Reaching over 10 million implants is not just a volume milestone—It is validation that TECNIS Eyhance IOL delivers consistent, real-world outcomes at scale,” said Paul Lisenby, Global Head of R&D, Vision, Johnson & Johnson. “That level of adoption reflects years of clinical evidence, surgeon trust, and performance under everyday visual conditions.”[1]
A Category-Defining Innovation with Proven Staying Power
Since its global introduction in 2019, TECNIS Eyhance IOL has transformed expectations for monofocal lenses by slightly extending the depth of focus, while preserving monofocal-like distance quality and image contrast, day and night.*³⁻⁵ Unlike other market options supported primarily by early optical modeling, TECNIS Eyhance IOL is backed by the highest quality and quantity of published clinical evidence across diverse patient populations and real-world practice settings.[4,9-10]
Clinical Performance That Translates Clearly to Patients and Surgeons
Built on the trusted TECNIS platform—celebrating more than 25 years of use in ophthalmology—TECNIS Eyhance IOL slightly extends depth of focus through a continuous increase in power while maintaining high quality distance vision.[*5-7]
What the clinical evidence shows:
- >26 studies demonstrating excellent contrast sensitivity, and some studies in low-light conditions[9,11]
- >48 studies demonstrating intermediate vision capabilities[4,9,13]
- >20 studies demonstrating TECNIS Eyhance IOL patients reporting low instances of visual disturbances (e.g., halos, starbursts, glare) [9,12]
TECNIS Eyhance IOL is part of the industry-leading TECNIS platform, combining advanced optics with proprietary material. The TECNIS portfolio also includes the new TECNIS PureSee IOL, a purely refractive EDOF IOL[14] and TECNIS Odyssey IOL, a Full Visual Range (FVR) IOL[15].
- 2026REF4047 – 10MM TECNIS Eyhance™ implants worldwide, sales data
- 2026REF4789 – Market Scope 2026 Global IOL Report, p. 15 & 60
- 2026REF4790 – Market Scope 2025 Quarterly Report, p. 5
- 2025PP09810 – Based on systemic literature review performed on November 4, 2024. TECNIS Eyhance Compendium is available upon request.
- DOF2021CT4002 – RUSH: TECNIS Eyhance™ IOL Monofocal Competitors MTF – US
- Data on file DOF2021CT4006, TECNIS Eyhance ™ Simulated Visual Acuity
- TECNIS Eyhance™ IOL with TECNIS SIMPLICITY™ Delivery System US DFU, Z311769E Rev. C.
- 2026REF4789 – Market Scope 2026 Global IOL Report, p. 102
- 2025PP05089 – TECNIS Eyhance™ and TECNIS Eyhance™ Toric II IOL Compendium 2024 – US. TECNIS Eyhance Compendium is available upon request.
- Nam, J. W., Lee, J. H., Zhang, H., Sung, M. S., & Park, S. W. (2023). Comparison of the Visual Outcomes of Enhanced and Standard Monofocal Intraocular Lens Implantations in Eyes with Early Glaucoma; Prospective study done at 3-month follow-up, TECNIS Eyhance™ IOL (N=34), TECNIS™ 1-Piece Monofocal IOL (N=38).
- 2025REF4273 – Garzon et al., Visual and Optical Quality of Enhanced Intermediate Monofocal Versus Standard Monofocal Intraocular Lens; Prospective study done at 3 month follow up, TECNIS Eyhance™ IOL (N=60 eyes), TECNIS™ 1 Piece Monofocal IOL (N=60 eyes)
- REF2023OTH5751 – Nam JW et al., Comparison of the Visual Outcomes of Enhanced and Standard Monofocal Intraocular Lens Implantations in Eyes with Early Glaucoma Prospective study done at 3 months follow up, TECNIS Eyhance™ IOL (N=34 eyes), TECNIS™ 1-Piece Monofocal (N=38 eyes)
- 2025REF4900 – Giglio et al., Visual Outcomes and Patient Satisfaction after Bilateral Implantation of an Enhanced Monofocal Intraocular Lens: a Single-Masked Prospective Randomized Study, Prospective study done at 3 months follow up, TECNIS Eyhance™ IOL (N=60 eyes), TECNIS ™ 1-Piece Monofocal IOL (N=60 eyes), Clareon® Monofocal IOL (N=60 eyes)
- TECNIS PureSee™ IOL with TECNIS SIMPLICITY™ Delivery System, Model DEN00V US DFU Z312075E rev B.
- TECNIS Odyssey™ IOL with TECNIS SIMPLICITY™ Delivery System, Model DRN00V. Directions for Use, current revision. Z311926E Rev. C*Based on modular transfer function bench test, ACE model, white light, 3mm & 5mm pupil sizes
